High drug prices due to unreasonable margins of companies: CCI

​​The CCI also prescribed various ways to reduce the anti-trade practices in the policy paper.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Jde7hx
via IFTTT